Long-term metastatic melanoma survival dramatically improves on immunotherapy

About half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a  report from Weill Cornell Medicine and Dana-Farber Cancer Center investigators.

Study reveals how COVID-19 infection can cause or worsen diabetes

Researchers have used a cutting-edge model system to uncover the mechanism by which SARS-CoV-2 induces new cases of diabetes and worsens complications in people who already have it.

Cornell experts to offer solutions at Climate Week NYC

Climate Week NYC will get a Big Red tint as Cornell researchers suggest carbon solutions for the travel industry, discuss agricultural methane and participate in a nuclear energy conference.

Mixing physical, virtual worlds to drive home climate urgency

The Communal eXtended-Reality (CXR) system is a cutting-edge blend of the physical and digital worlds in which virtual scenes are overlaid onto the real world, designed to engage communities in new ways. 

Brain scanning approach shows wiring of depression

By repeatedly scanning the brains of a small group of patients for a year and a half, Weill Cornell Medicine researchers have identified a distinct pattern of neuronal interactions that appears to predispose some people to developing depression.

Human Ecology launches internship in New York City

Students work at partner sites across the city’s five boroughs, with a focus on urban studies, community engagement and professional development.

Around Cornell

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before risk of contracting the potentially fatal infection dramatically increases in adolescence.

Machine learning helps identify rheumatoid arthritis subtypes

The study shows that artificial intelligence and machine learning technologies can effectively and efficiently subtype pathology samples from patients with rheumatoid arthritis.

The role of an energy-producing enzyme in treating Parkinson’s

An enzyme called PGK1 has an unexpectedly critical role in the production of chemical energy in brain cells, according to a preclinical study led by researchers at Weill Cornell Medicine.